Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Caveolin-1 and breast cancer: a new clinical perspective.

Advances in experimental medicine and biology - 1 Jan 2012

Mercier Isabelle, Lisanti Michael P

Abstract excerpt

The current chapter focuses on the role of Caveolin-1 (Cav-1) in cellular growth with an emphasis on its implication in breast cancer initiation, progression, clinical prognosis and as a potential therapeutic target. The role of Cav-1 as a tumor suppressor in breast cancer has emerged in the past few years, with dual functions on both cancer epithelium as well as the cancer stroma. Its multiple functions as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Caveolin 1
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogens

Share to Mutation

Share to Signal Transduction

Share to Tumor Suppressor Proteins

Source

Identifiers

PMID: 22411315
DOI: 10.1007/978-1-4614-1222-9_6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Caveolin-1 and breast cancer: a new clinical perspective.PMID 22411315Read ↗

Caveolin in breast cancerSemantic proximity Read ↗

Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.Semantic proximity Read ↗

Caveolin-1 Deficiency (−/−) Conveys Premalignant Alterations in Mammary Epithelia, with Abnormal Lumen Formation, Growth Factor Independence, and Cell InvasivenessSemantic proximity Read ↗

Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapySemantic proximity Read ↗

RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.Semantic proximity Read ↗

The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.Semantic proximity Read ↗

Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.Semantic proximity Read ↗

Caveolin-1 promotes mammary tumorigenesis: mutational profile of the Kashmiri population.Semantic proximity Read ↗

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.Semantic proximity Read ↗

Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation.Semantic proximity Read ↗

Loss of either RASSF1A alone or in combination with Caveolin-1 inhibition is associated with different premalignant histopathological alterations in the mammary glands of transgenic miceSemantic proximity Read ↗

Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.